U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07402551) titled 'Phase II Study of RC1416 Injection in COPD' on Jan. 28.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of RC1416 injection in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Study Start Date: March 07
Study Type: INTERVENTIONAL
Condition:
Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
DRUG: RC1416
There are two doses in this part. Each subjects will receive the drug by subcutaneous injection.
DRUG: RC1416 Placebo
Each subjects will receive the placebo by subcutaneous i...